Alexandria Real Estate Equities Inc  

(Public, NYSE:ARE)   Watch this stock  
Find more results for Joel Richardson�
74.04
+0.45 (0.61%)
Real-time:   12:35PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 73.42 - 74.17
52 week 60.86 - 78.43
Open 73.91
Vol / Avg. 223,460.00/375,286.00
Mkt cap 5.30B
P/E 46.89
Div/yield 0.70/3.78
EPS 1.58
Shares 71.64M
Beta 0.97
Inst. own 107%
May 6, 2014
Q1 2014 Alexandria Real Estate Equities Inc Earnings Conference Call - 3:00PM EDT - Add to calendar
May 5, 2014
Q1 2014 Alexandria Real Estate Equities Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 2, 2014
Alexandria Real Estate Equities Inc at Citi Global Property Conference
Feb 4, 2014
Alexandria Real Estate Equities Incorporated Fourth Quarter 2013 Results Conference Call - Webcast
Feb 3, 2014
Q4 2013 Alexandria Real Estate Equities Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 23.88% 21.31%
Operating margin 34.41% 32.08%
EBITD margin - 62.38%
Return on average assets 2.17% 1.83%
Return on average equity 4.13% 3.27%
Employees 217 -
CDP Score - -

Address

SUITE 299, 385 E. COLORADO BLVD
PASADENA, CA 91101
United States - Map
+1-626-5780777 (Phone)
+1-626-5780896 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company is an owner and REIT, and life science real estate company, focused on science-driven cluster development through the ownership, operation, management, selective acquisition, development, and redevelopment of properties containing life science laboratory space. The Company is a provider of real estate, technical infrastructure, and services to the life science industry. Client tenants include institutional (universities and independent non-profit institutions), pharmaceutical, biotechnology, medical device, product, and service entities and government agencies, , medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As of December 31, 2012, the Company�s operating properties were approximately 93.4% leased.

Officers and directors

Joel S. Marcus J.D., CPA Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Dean A. Shigenaga Chief Financial Officer, Executive Vice President, Treasurer
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen A. Richardson Chief Operating Officer, Regional Market Director - San Francisco
Age: 52
Bio & Compensation  - Reuters
Thomas J. Andrews Executive Vice President, Regional Market Director � Greater Boston
Age: 45
Bio & Compensation  - Reuters
Daniel J. Ryan Executive Vice President, Regional Market Director � San Diego and Strategic Operations
Age: 47
Bio & Compensation  - Reuters
Peter M. Moglia Chief Investment Officer
Age: 46
Bio & Compensation  - Reuters
Richard B. Jennings Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
James H. Richardson Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John L. Atkins III Independent Director
Age: 69
Bio & Compensation  - Reuters
Maria C. Freire Ph.D. Independent Director
Age: 59
Bio & Compensation  - Reuters